Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Haematopoietic stem cell gene therapy with IL ‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA
Helen Parker, Stuart Ellison, Rebecca Holley, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 3
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy
Yasuhiko Ago, Estera Rintz, Krishna Musini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1113-1113
Open Access | Times Cited: 8
Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets
Andrés Felipe Leal, Eliana Benincore-Flórez, Estera Rintz, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 477-477
Open Access | Times Cited: 34
Innate Immunity in Mucopolysaccharide Diseases
Oriana Mandolfo, Helen Parker, Brian Bigger
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1999-1999
Open Access | Times Cited: 31
Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT
Xuefang Pan, Mahsa Taherzadeh, Poulomee Bose, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 8
Open Access | Times Cited: 24
Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas
Yujie Ding, Jie Yi, Jinxin Wang, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e14960-e14960
Open Access | Times Cited: 13
Constitutive IL-1RA production by modified immune cells protects against IL-1–mediated inflammatory disorders
Mariasilvia Colantuoni, Raisa Jofra Hernández, Emanuela Pettinato, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 698
Closed Access | Times Cited: 13
Single-cell RNA sequencing reveals important role of monocytes and macrophages during mucopolysaccharidosis treatment
Gaohui Zhu, Yue Xie, Li Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
High dose genistein in Sanfilippo syndrome: A randomised controlled trial
Arunabha Ghosh, Stewart Rust, Kia Langford‐Smith, et al.
Journal of Inherited Metabolic Disease (2021) Vol. 44, Iss. 5, pp. 1248-1262
Open Access | Times Cited: 29
The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy
Anna‐Maria Wiesinger, Brian Bigger, Roberto Giugliani, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Heterologous HSPC Transplantation Rescues Neuroinflammation and Ameliorates Peripheral Manifestations in the Mouse Model of Lysosomal Transmembrane Enzyme Deficiency, MPS IIIC
Xuefang Pan, Antoine Caillon, Shuxian Fan, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 877-877
Open Access | Times Cited: 3
Noradrenergic Signaling and Neuroinflammation Crosstalk Regulate Toxoplasma gondii-Induced Behavioral Changes
Conor Laing, Nicolas Blanchard, Glenn A. McConkey
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1072-1082
Open Access | Times Cited: 25
Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood‐onset dementia
Leanne K. Winner, Mary‐Louise Rogers, Marten F. Snel, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 3, pp. 481-496
Open Access | Times Cited: 8
Hematopoietic stem cell gene therapy to halt neurodegeneration
Alessandra Biffi
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00440-e00440
Open Access | Times Cited: 2
Brain and visceral gene editing of mucopolysaccharidosis I mice by nasal delivery of the CRISPR/Cas9 system
Luisa Natália Pimentel Vera, Roselena Silvestri Schuh, Flávia Nathiely Silveira Fachel, et al.
The Journal of Gene Medicine (2022) Vol. 24, Iss. 4
Closed Access | Times Cited: 12
New Indications for Hematopoietic Stem Cell Gene Therapy in Lysosomal Storage Disorders
Linda Rossini, Caterina Durante, Antonio Marzollo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Update of treatment for mucopolysaccharidosis type III (sanfilippo syndrome)
Weijing Kong, Yanqing Yao, Jing Zhang, et al.
European Journal of Pharmacology (2020) Vol. 888, pp. 173562-173562
Closed Access | Times Cited: 16
Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases
Estera Rintz, Takashi Higuchi, Hiroshi Kobayashi, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 24, pp. 71-87
Open Access | Times Cited: 15
An Engineered sgsh Mutant Zebrafish Recapitulates Molecular and Behavioural Pathobiology of Sanfilippo Syndrome A/MPS IIIA
Alon M. Douek, Mitra Amiri Khabooshan, Jason Henry, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5948-5948
Open Access | Times Cited: 13
Evidence for inflammasome activation in the brain of mucopolysaccharidosis type II mice
Amanda Stapenhorst Azambuja, Luisa N. Pimentel-Vera, Esteban Alberto Gonzalez, et al.
Metabolic Brain Disease (2020) Vol. 35, Iss. 7, pp. 1231-1236
Closed Access | Times Cited: 13
Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?
Noemi Veraldi, Isabelle Dentand Quadri, Yohan van de Looij, et al.
Carbohydrate Polymers (2023) Vol. 320, pp. 121214-121214
Open Access | Times Cited: 4
Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy
Stuart Ellison, Aiyin Liao, Hélène F.E. Gleitz, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101127-101127
Open Access | Times Cited: 4
Anakinra in Sanfilippo syndrome: a phase 1/2 trial
Lynda E. Polgreen, Agnes H. Chen, Youngju Pak, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2473-2479
Open Access | Times Cited: 1
Plasma and CSF biomarkers of aging and cognitive decline in Caribbean vervets
Curran Varma, Eva Luo, Gustaf Boström, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5460-5480
Open Access | Times Cited: 1
Extracellular vesicles from microglial cells activated by abnormal heparan sulfate oligosaccharides from Sanfilippo patients impair neuronal dendritic arborization
Chloé Dias, Nissrine Ballout, Guillaume Morla, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top